News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
354,983 Results
Type
Article (33285)
Company Profile (126)
Press Release (321572)
Section
Business (94813)
Career Advice (621)
Deals (14440)
Drug Delivery (54)
Drug Development (50505)
Employer Resources (57)
FDA (7748)
Job Trends (8255)
News (168659)
Policy (16616)
Tag
Academia (2282)
Alliances (28407)
Alzheimer's disease (678)
Antibody-drug conjugate (ADC) (89)
Approvals (7739)
Artificial intelligence (90)
Bankruptcy (118)
Best Places to Work (7151)
Biotechnology (99)
Breast cancer (200)
Cancer (1451)
Career advice (538)
CAR-T (89)
Cell therapy (227)
Clinical research (39475)
Collaboration (331)
Compensation (80)
COVID-19 (1656)
C-suite (68)
Data (900)
Diabetes (69)
Diagnostics (4179)
Earnings (28611)
Events (53763)
Executive appointments (222)
FDA (8159)
Funding (273)
Gene therapy (82)
GLP-1 (234)
Government (3233)
Healthcare (12079)
Infectious disease (1707)
Inflammatory bowel disease (61)
Interviews (90)
IPO (7263)
Job creations (1382)
Job search strategy (484)
Layoffs (184)
Legal (3001)
Liver cancer (70)
Lung cancer (218)
Lymphoma (96)
Manufacturing (103)
Medical device (4739)
Medtech (4739)
Mergers & acquisitions (7276)
Metabolic disorders (156)
Neuroscience (807)
NextGen Class of 2024 (4050)
Non-profit (4013)
Northern California (933)
Obesity (72)
Opinion (107)
People (30624)
Phase I (13799)
Phase II (17279)
Phase III (12300)
Pipeline (310)
Policy (61)
Postmarket research (1493)
Preclinical (6046)
Prostate cancer (69)
Radiopharmaceuticals (234)
Rare diseases (126)
Real estate (2593)
Regulatory (11315)
Research institute (2156)
Resumes & cover letters (76)
Southern California (762)
Startups (1982)
United States (8189)
Vaccines (349)
Date
Today (54)
Last 7 days (297)
Last 30 days (1387)
Last 365 days (19632)
2024 (19558)
2023 (22207)
2022 (29371)
2021 (31434)
2020 (30368)
2019 (27322)
2018 (20253)
2017 (16965)
2016 (16755)
2015 (19413)
2014 (14716)
2013 (12068)
2012 (12594)
2011 (13150)
2010 (11753)
Location
Africa (411)
Arizona (82)
Asia (23295)
Australia (4294)
California (1979)
Canada (767)
China (243)
Colorado (86)
Connecticut (97)
Delaware (61)
Europe (46631)
Florida (291)
Georgia (65)
Illinois (253)
Indiana (112)
Maryland (434)
Massachusetts (1489)
Minnesota (128)
New Jersey (685)
New York (671)
North Carolina (329)
Northern California (933)
Ohio (74)
Pennsylvania (406)
South America (510)
Southern California (762)
Texas (389)
Washington State (263)
354,983 Results for "nih nci national cancer institute".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Chimeron Bio receives NIH (NCI) Innovative Concept Award for mRNA cancer vaccine development
Chimeron Bio, a Philadelphia -headquartered biotech company, has received a 2024 National Institutes of Health’s Small Business Innovation Research Innovative Concept Award through the National Cancer Institute.
April 16, 2024
·
1 min read
Pharm Country
Xylyx Bio Awarded $2.26M NIH SBIR Grant from National Cancer Institute
Xylyx Bio, Inc. announced that it has been awarded a Small Business Innovation Research Fast-Track grant from the National Cancer Institute of the National Institutes of Health to advance commercial development of its InMatrico® disease modeling and drug testing platform to help scientists discover and test drug candidates for metastatic breast cancer.
June 14, 2024
·
2 min read
Press Releases
SciTech Development, Inc. Announces Receipt of Drug Supply From The National Cancer Institute (NCI)
September 18, 2024
·
2 min read
Business
BlueSphere Bio Establishes Strategic Collaboration with the National Cancer Institute to Advance Treatments for Rare Respiratory Disease
BlueSphere Bio, a T-cell receptor (TCR) T-cell therapy company utilizing a powerful TCR discovery platform to identify novel therapeutic candidates for patients with hematologic malignancies and solid tumors, today announced a strategic collaboration with the National Cancer Institute (NCI), part of the National Institutes of Health.
June 4, 2024
·
5 min read
Business
LIXTE Biotechnology Enters into Exclusive Immune Oncology Patent License Agreement with NINDS and NCI
LIXTE Biotechnology Holdings, Inc. ( Nasdaq: LIXT and LIXTW ) (“LIXTE” or the “Company”) today announced the signing of an exclusive patent license agreement with the National Institute of Neurological Disorders and Stroke (NINDS) and National Cancer Institute (NCI), each a component of the National Institute of Health (NIH).
February 26, 2024
·
4 min read
Press Releases
Biosplice Therapeutics Announces Initiation of Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) Trial Sponsored by the National Cancer Institute (NCI)
September 12, 2024
·
4 min read
Business
ATCC Announces Award from the National Cancer Institute to Provide Biospecimen Processing Services and Assays for Cancer Research
ATCC will continue to support the National Cancer Institute’s (NCI) mission to prevent cancer and the Division of Cancer Epidemiology and Genetics (DCEG) Biospecimen Activity and Assay Support (BAAS) program.
March 19, 2024
·
3 min read
Press Releases
NIH clinical trial will test precision medicine treatments for myeloid cancers
October 24, 2024
·
4 min read
BioCapital
NIH scientists develop AI tool to predict how cancer patients will respond to immunotherapy
In a proof-of-concept study, researchers at the National Institutes of Health have developed an artificial intelligence tool that uses routine clinical data, such as that from a simple blood test, to predict whether someone’s cancer will respond to immune checkpoint inhibitors, a type of immunotherapy drug that helps immune cells kill cancer cells.
June 3, 2024
·
4 min read
BioMidwest
Lamassu Awarded NIH Grant For Breakthrough Cancer Treatment
Lamassu Bio Inc. has been awarded a grant from the National Institutes of Health and National Cancer Institute for the development of their groundbreaking treatment for p53 wild-type sarcomas.
March 12, 2024
·
3 min read
1 of 35,499
Next